Search

Displaying results 9801 - 9810 of 10000 in total
  1. Drug

    Lutetium Lu-177 DOTA-ABM-5G

    go.drugbank.com/drugs/DB33946
    Experimental

    Lutetium Lu-177 DOTA-ABM-5G is under investigation in clinical trial NCT06389123 (Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas). … Lutetium Lu-177 DOTA-ABM-5G is a biologic drug.

  2. Drug

    Tarazepide

    go.drugbank.com/drugs/DB06435
    Experimental

  3. Drug

    Lixivaptan

    go.drugbank.com/drugs/DB06666
    Investigational

  4. Drug

    PRX-03140

    go.drugbank.com/drugs/DB05596
    Investigational

  5. Drug

    Aplindore

    go.drugbank.com/drugs/DB06620
    Investigational

  6. Drug

    UV1

    go.drugbank.com/drugs/DB18470
    Experimental

    UV1 is a cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit

  7. Drug

    FCR001

    go.drugbank.com/drugs/DB18595
    Investigational

    FCR001 is a somatic cell therapy product containing hematopoietic progenitor cells (HPC), Facilitating Cells (FC), and alpha beta T cells.

  8. Drug

    Leptazoline A

    go.drugbank.com/drugs/DB15551
    Experimental

    Leptazoline A is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline B], [Leptazoline C], and [Leptazoline D].

  9. Drug

    Leptazoline B

    go.drugbank.com/drugs/DB15552
    Experimental

    Leptazoline B is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline C], and [Leptazoline D].

  10. Drug

    Leptazoline C

    go.drugbank.com/drugs/DB15553
    Experimental

    Leptazoline C is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline B], and [Leptazoline D].